Ocugen Inc (OCGN)

Short-squeeze stocks are as popular as ever among retail investors. This list contains some of the high-short-interest names you may not have heard of before.

Throw in The Towel, Ocugen Stock is Not Coming Back

By Thomas Niel, InvestorPlace Contributor Aug 2, 2021

Barring the slim chance it gets EUA in Canada, which admittedly could result in an outsized move higher? Expect OCGN stock to continue trending lower, eventually falling back to around 70 cents per share.

Is Ocugen Worth a Shot Because of the Worsening Pandemic?

By Josh Enomoto, InvestorPlace Contributor Jul 29, 2021

While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.

Ocugen Likely Can’t Get a Boost From the FDA Until 2023

By Larry Ramer, InvestorPlace Contributor Jul 22, 2021

It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete. Sell OCGN stock.

Covid Vaccine Stocks: Why NVAX, OCGN, MRNA and QDEL Are on the Move Today

By William White, InvestorPlace Writer Jul 20, 2021

Stocks for companies developing or already distributing a vaccine for covid are on the move Tuesday and we've got all the details.

Ocugen Stock Is Well Past Its Expiration Date and It Shows

By Joseph Nograles Jul 16, 2021

There won’t be a market for COVAXIN in the US as vaccination rates continue moving up. Without a successful US launch of COVAXIN, OCGN stock doesn’t even warrant the price of a dollar.

9 Lesser-Known Short-Squeeze Stocks Popular With Retail Investors

By William White, InvestorPlace Writer Jul 15, 2021

We're taking a look at some of the lesser-known short-squeeze stocks popular with retail investors that should be on your radar.

Ocugen’s Recent Vaccine Efficacy Results Should Have Traders Cheering

By Louis Navellier and the InvestorPlace Research Staff Jul 12, 2021

While the Delta variant Covid-19 strain threatens the population, OCGN stock investors can count on Ocugen to advance its vaccine candidate.

The Outlook for Ocugen Stock Has Deteriorated Further

By Larry Ramer, InvestorPlace Contributor Jul 7, 2021

Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for some time. OCGN remains a good stock to short.

7 Meme Stocks to Buy for Their ‘To-the-Moon’ Potential

By Tezcan Gecgil, InvestorPlace Contributor Jul 6, 2021

These seven meme stocks to buy could be good picks for July as investor interest in these high-risk, high-return plays continues to grow.

3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory

By Alex Sirois, InvestorPlace Contributor Jul 6, 2021

OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward.

What Will the Stock Market Do Today? 3 Big Stories to Watch.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Jul 6, 2021

So what will the stock market do today? All eyes are on Didi stock and r/WallStreetBets drama from this weekend.

OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today

By Robert Lakin, InvestorPlace Contributor Jul 6, 2021

Ocugen's Indian vaccine development partner reported better-than-expected results from its local Covid-19 vaccine trials. OCGN stock has been on a roller-coaster ride on every Covaxin rumor and news item.